Starling Medical, Inc.

Houston, TX

UEI
ZKC9CKSKCMS4
CAGE
8HAG4
Primary NAICS
339112 Surgical and Medical Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2450 Holcombe Blvd #1320, Houston, TX 77021, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

About the company

Starling Medical, Inc. is a minority-owned, self-certified small disadvantaged business and for-profit Hispanic American-owned manufacturer of goods. It was registered in SAM.gov on February 12, 2020, and its registration is set to expire on July 10, 2024.

Through a prime federal grant award from the National Science Foundation, Starling Medical received $255,988 for a project titled "SBIR PHASE I: A TECH-ENABLED URINARY CATHETER FOR PATIENTS WITH NEUROGENIC BLADDER DYSFUNCTION" from December 1, 2020, to May 31, 2022. The scope of work for this award involved aiding product development and regulatory development, contributing to the further industrial, mechanical, and electrical design of the company's diagnostic platform and prosthesis-like device. Additionally, Starling Medical received two sub-federal grant awards from The Regents of the University of California, San Francisco. The scope of work for these sub-awards was identical, with all funding going towards aiding product development and regulatory development, contributing to the further industrial, mechanical, and electrical design of the company's diagnostic platform and prosthesis-like device.

Quick answers

Is Starling Medical, Inc. registered in SAM.gov?

Yes. Starling Medical, Inc.'s SAM.gov registration is active through May 28, 2027.

What is Starling Medical, Inc.'s most recent federal award?

Starling Medical, Inc.'s most recent federal grant award is Sbir phase i: a tech-enabled urinary catheter for patients with neurogenic bladder dysfunction (2036190), from Division of Industrial Innovation, on December 1, 2020.

On GovTribe

See Starling Medical, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors